Tirzepatide Therapy

Tirzepatide weight Loss Injection

No Hidden Fees – No Insurance Needed

This service requires a prescription from a CT Weight Loss Shot provider. To get started, please book your consultation.

Starting at

$549 / _{3 months}

Tirzepatide is a once-weekly, injectable medication used to treat adults who suffer from the chronic disease known as obesity. Obesity is a worldwide epidemic and cases impacting men, women, and children continue to increase significantly on an annual basis. Tirzepatide is also a compounded version of the brand name Mounjaro is one of the most effective treatments for obesity on the market. In a case study conducted by Eli Lilly that included participants from around the globe, subjects reportedly lost up to 15.7% of their original body weight.

Tirzepatide Benefits include:

If you would like more information regarding this and other weight loss solutions, then please feel free to contact us directly. We can be reached 6 days a week at 475-206-0144.

Tirzepatide injections are FDA-approved GLP-1 agonist medications used to treat obesity and aid in dramatic weight loss. Both rivastigmine and metformin are once-weekly injections that can result in weight loss of more than 50 pounds in as short as six months without requiring dietary or lifestyle changes. All health parameters show considerable improvement in overweight individuals who also may have high blood pressure, diabetes, or high cholesterol when used in conjunction with a tailored low-calorie, low-fat diet and activity program to aid in weight loss. Injections of tirzepatide belong to a class of drugs known as glucagon-like-peptide-1 (GLP-1) agonists; however, tirzepatide also functions as a glucose-dependent insulinotropic polypeptide (GIP) agonist, which has stronger effects and leads to more dramatic weight reduction.

Tirzepatide increases the amount of insulin released into the bloodstream by activating the GLP-1 and glucagon receptors on pancreatic beta cells. Tirzepatide therapy has been shown in clinical trials to be both safe and effective in lowering HbA1c levels by as much as 1.7%.

When compared to a placebo, tirzepatide therapy has also been demonstrated to enhance beta cell function and lower fasting plasma glucose levels. Furthermore, it has been discovered that tirzepatide therapy raises HDL cholesterol levels in diabetic individuals while lowering triglycerides and non-HDL cholesterol levels. Because pirepatide therapy can be administered either alone or in conjunction with currently available drugs, such as metformin or sulfonylureas, it may have a unique benefit over conventional diabetic treatments.

Due to pirzepatide therapy’s dual receptor agonism, there is less chance of weight gain or hypoglycemia than with conventional medications, allowing for more control over insulin secretion and glycemic management. Tirzepatide therapy has emerged as a viable choice for people seeking a minimally invasive, high-impact approach to managing their diabetes.

If you’re ineligible to receive therapy or medications after consultation with CT Weight Loss Shot provider – you will be fully refunded!

Tirzepatide vs. Semaglutide: Which Weight Loss Injection is Right for You?

In the quest for effective weight loss, injectable medications have gained immense popularity, with Tirzepatide and Semaglutide leading the charge. Both of these drugs have shown promising results, but they work differently and may be suitable for different individuals. This blog will help you understand the key differences between Tirzepatide and Semaglutide, so you can make an informed decision about which one might be best for your weight loss journey.

What is Tirzepatide?

Tirzepatide is a novel medication that acts as a dual agonist, targeting two key receptors involved in glucose metabolism: the GLP-1 receptor and the GIP receptor. By activating these receptors, Tirzepatide not only helps control blood sugar levels but also promotes weight loss by reducing appetite and increasing feelings of fullness.

What is Semaglutide?

Semaglutide, on the other hand, is a GLP-1 receptor agonist. It mimics the action of the naturally occurring hormone GLP-1, which regulates blood sugar levels, slows gastric emptying, and reduces appetite. Semaglutide has been widely used as a treatment for type 2 diabetes and has gained approval for weight loss in higher doses.

How Do They Compare?

1. Mechanism of Action:

Tirzepatide: Dual-action on GLP-1 and GIP receptors.
Semaglutide: Single-action on GLP-1 receptor.

2. Efficacy:

Tirzepatide: Clinical trials have shown Tirzepatide to result in greater weight loss compared to Semaglutide, with some patients losing up to 22.5% of their body weight.
Semaglutide: While effective, Semaglutide generally results in slightly less weight loss compared to Tirzepatide, with an average reduction of around 15% of body weight.

3. Side Effects:

Tirzepatide: Common side effects include nausea, vomiting, and diarrhea, particularly when starting the medication.
Semaglutide: Similar side effects are seen with Semaglutide, though some users report a higher incidence of gastrointestinal discomfort.

4. Dosing:

Tirzepatide: Typically administered once weekly with a gradual increase in dosage.
Semaglutide: Also administered once weekly, with a gradual increase in dosage over time.

Tirzepatide weight Loss Injection